title: Is the spectrum of mutations in Indian patients with cystic fibrosis different?
authors.forename: M
authors.initials: M
authors.lastname: Kabra
authors.forename: S K
authors.initials: SK
authors.lastname: Kabra
authors.forename: M
authors.initials: M
authors.lastname: Ghosh
authors.forename: A
authors.initials: A
authors.lastname: Khanna
authors.forename: S
authors.initials: S
authors.lastname: Arora
authors.forename: P S
authors.initials: PS
authors.lastname: Menon
authors.forename: I C
authors.initials: IC
authors.lastname: Verma
authors.forename: A
authors.initials: A
authors.lastname: Wallace
mesh_terms: D000328:Adult; D017398:Alternative Splicing / Q000235:genetics; D019943:Amino Acid Substitution; D001483:Base Sequence; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000235:genetics* / Q000473:pathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D004247:DNA / Q000737:chemistry / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D007194:India; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016254:Mutagenesis, Insertional; D009154:Mutation; D017354:Point Mutation; D018807:Polymorphism, Single-Stranded Conformational
chemical_list: C505032:CFTR protein, human; C093349:cystic fibrosis transmembrane conductance regulator delta F508; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D004247:DNA